Clinical Features of Gout and Its Impact on Quality of Life

Gout ◽  
2019 ◽  
pp. 113-117
Author(s):  
N. Lawrence Edwards
2019 ◽  
Vol 17 (7) ◽  
pp. 1285-1294.e1 ◽  
Author(s):  
William L. Hasler ◽  
Laura A. Wilson ◽  
Linda A. Nguyen ◽  
William J. Snape ◽  
Thomas L. Abell ◽  
...  

2017 ◽  
Vol 29 (6) ◽  
pp. 974-977 ◽  
Author(s):  
Jiyeon Lee ◽  
Jung-hee Kim ◽  
Eun-jung Jung ◽  
Byoung-Hee Lee

2020 ◽  
Vol 21 (21) ◽  
pp. 8406
Author(s):  
Eriko Komiya ◽  
Mitsutoshi Tominaga ◽  
Yayoi Kamata ◽  
Yasushi Suga ◽  
Kenji Takamori

Itch (or pruritus) was not previously recognized as a serious symptom of psoriasis. However, approximately 60–90% of psoriatic patients with pruritus have stated that it deteriorates their quality of life. Since conventional antipruritic therapies, such as antihistamines, only exert limited effects, the establishment of a treatment option for itch in psoriasis is urgently needed. Although a definitive drug is not currently available, various itch mediators are known to be involved in pruritus in psoriasis. In this review, we describe the clinical features of pruritus in psoriasis, classify a wide range of itch mediators into categories, such as the nervous, immune, endocrine, and vascular systems, and discuss the mechanisms by which these mediators induce or aggravate itch in the pathophysiology of psoriasis.


2010 ◽  
Vol 26 (1) ◽  
pp. 151-155 ◽  
Author(s):  
J. D. Herrero-Morin ◽  
J. Rodriguez ◽  
E. Coto ◽  
H. Gil-Pena ◽  
V. Alvarez ◽  
...  

2007 ◽  
Vol 50 (9) ◽  
pp. 1450-1459 ◽  
Author(s):  
Bo Shen ◽  
Victor W. Fazio ◽  
Feza H. Remzi ◽  
Ana E. Bennett ◽  
Ian C. Lavery ◽  
...  

Medicine ◽  
2008 ◽  
Vol 87 (6) ◽  
pp. 301-310 ◽  
Author(s):  
Jeroen C. H. van der Hilst ◽  
Evelien J. Bodar ◽  
Karyl S. Barron ◽  
Joost Frenkel ◽  
Joost P. H. Drenth ◽  
...  

2014 ◽  
Vol 41 (11) ◽  
pp. 2260-2269 ◽  
Author(s):  
Jaime Guzman ◽  
Oralia Gómez-Ramírez ◽  
Roman Jurencak ◽  
Natalie J. Shiff ◽  
Roberta A. Berard ◽  
...  

Objective.To assess which clinical features are most important for patients, parents, and clinicians in the course of juvenile idiopathic arthritis (JIA).Methods.Forty-nine people participated in 6 audience-specific focus group discussions and 112 reciprocal interviews in 3 Canadian cities. Participants included youth with JIA, experienced English- and French-speaking parents, novice parents (< 6 mos since diagnosis), pediatric rheumatologists, and allied health professionals. Participants discussed the importance of 34 JIA clinical features extracted from medical literature. Transcripts and interview reports underwent qualitative analysis to establish relative priorities for each group.Results.Most study participants considered medication requirements, medication side effects, pain, participant-defined quality of life, and active joints as high priority clinical features of JIA. Active joint count was the only American College of Rheumatology core variable accorded high or medium priority by all groups. Rheumatologists and allied health professionals considered physician global assessment as high priority, but it had very low priority for patients and parents. The parent global assessment was considered high priority by clinicians, medium to high by parents, and low by patients. Child Health Assessment Questionnaire scores were considered low priority by patients and parents, and moderate or high by clinicians. The number of joints with limited motion was given low to very low priority by all groups. Parents gave high priority to arthritis flares.Conclusion.If our findings are confirmed, medication requirements, medication side effects, pain, participant-defined quality of life, and active joint counts should figure prominently in describing the course of JIA.


Sign in / Sign up

Export Citation Format

Share Document